Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-386464

Chief Financial Officer sold 17,717 shares at $18.94 ($335,560)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-08 Sale : show line 1 in the form 10b5-1 −17,717 $18.94 $335,560 122,851 D
Open-market sales · 17,717 sh · avg $18.94 · $335,560
Loading xslF345X06/ownership.xml…